Barbara Troupin - Net Worth and Insider Trading

Barbara Troupin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara Troupin owns 3 companies in total, including Neoleukin Therapeutics Inc (NLTX) , Seelos Therapeutics Inc (SEELQ) , and Equillium Inc (EQ) .

Click here to see the complete history of Barbara Troupin’s form 4 insider trades.

Insider Ownership Summary of Barbara Troupin

Ticker	Company	Transaction Date	Type of Owner
NLTX	Neoleukin Therapeutics Inc	2016-10-03	Chief Medical Officer
SEELQ	Seelos Therapeutics Inc	2014-12-12	Chief Medical Officer
EQ	Equillium Inc	2022-02-24	director

Barbara Troupin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barbara Troupin Ownership Network

Ownership Network List of Barbara Troupin

No Data

Ownership Network Relation of Barbara Troupin

Barbara Troupin Owned Company Details

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Barbara Troupin is the Chief Medical Officer of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

What does Seelos Therapeutics Inc do?

Who are the key executives at Seelos Therapeutics Inc?

Barbara Troupin is the Chief Medical Officer of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include director & See Remarks Raj Mehra , Chief Financial Officer Michael Joseph Golembiewski , and SVP & Chief Business Officer Neil Morton .

Seelos Therapeutics Inc (SEELQ) Insider Trades Summary

Over the past 18 months, Barbara Troupin made no insider transaction in Seelos Therapeutics Inc (SEELQ). Other recent insider transactions involving Seelos Therapeutics Inc (SEELQ) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski , and a net purchase of 75,757 shares made by Raj Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEELQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEELQ) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.

Seelos Therapeutics Inc (SEELQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seelos Therapeutics Inc Insider Transactions

No Available Data

What does Equillium Inc do?

Who are the key executives at Equillium Inc?

Barbara Troupin is the director of Equillium Inc. Other key executives at Equillium Inc include Chief Financial Officer Jason A Keyes , Sr. Vice President and COO Christine Zedelmayer , and director & Chief Scientific Officer Stephen Connelly .

Equillium Inc (EQ) Insider Trades Summary

Over the past 18 months, Barbara Troupin made no insider transaction in Equillium Inc (EQ). Other recent insider transactions involving Equillium Inc (EQ) include a net sale of 40,000 shares made by Jason A Keyes , a net sale of 42,324 shares made by , and a net sale of 15,000 shares made by Christine Zedelmayer .

In summary, during the past 3 months, insiders sold 0 shares of Equillium Inc (EQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 97,324 shares of Equillium Inc (EQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,324 shares.

Equillium Inc (EQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Equillium Inc Insider Transactions

No Available Data

Barbara Troupin Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara Troupin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Barbara Troupin's mailing address is: La Jolla Ca 92037.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.